×
ADVERTISEMENT

APRIL 14, 2025

Why Visibility Into DSCSA Readiness Data Is Key to Compliance

By Rob DeWig

When the FDA announced it wouldn’t fully enforce the Drug Supply Chain Security Act (DSCSA) in 2024, opting instead for staggered deadlines, this wasn’t just another delay—it was a strategic shift. Given how serialization data flow from manufacturers down to wholesalers, distributors and pharmacies, expecting full compliance from everyone simultaneously was always unrealistic. A phased approach makes sense because serialization starts at the top, and each supply